| Andrew Y. Chao, Inc | |
|
683 Big Bend Rd Ballwin MO 63021-7723 | |
| (636) 227-1511 | |
| (636) 227-2452 |
| Full Name | Andrew Y. Chao, Inc |
|---|---|
| Speciality | Family Medicine |
| Location | 683 Big Bend Rd, Ballwin, Missouri |
| Authorized Official Name and Position | Dailing Chao (OFFICE SUPERVISER) |
| Authorized Official Contact | 6362271511 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Andrew Y. Chao, Inc 683 Big Bend Rd Ballwin MO 63021-7723 Ph: (636) 227-1511 | Andrew Y. Chao, Inc 683 Big Bend Rd Ballwin MO 63021-7723 Ph: (636) 227-1511 |
| NPI Number | 1780802108 |
|---|---|
| Provider Enumeration Date | 04/23/2007 |
| Last Update Date | 08/07/2007 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780802108 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | R2A51 (Missouri) | Primary |
News Archive
Extending an unmatched record of innovation in the field of endovascular aortic repair, Medtronic, Inc., today announced the U.S. market launch of the Talent Thoracic Stent Graft on the Xcelerant Delivery System, which makes minimally-invasive treatment of thoracic aortic aneurysms easier to perform.
Lux Biosciences, Inc. today announced that the European Medicines Agency has accepted the filing of the company's Marketing Authorization Application (MAA) for the company's lead product, Luveniq™ (LX211; oral voclosporin) for the treatment of noninfectious uveitis involving the intermediate or posterior segments of the eye.
CoLucid Pharmaceuticals, Inc., an innovative biotechnology company focusing on therapies for central nervous system disorders, announced Phase II results of its lead compound COL-144 in the treatment of acute migraine. Results demonstrated that COL-144 was safe and effective in relieving migraine headaches.
The retrospective CRYSTAL analysis was conducted as a result of an effort to increase the tissue ascertainment rate to determine the K-ras status of patients' tumors. The analysis included extended patient follow up of nearly 1.5 years and doubled the tissue ascertainment rate from 45% to 89%. These data are an update from the overall survival results from CRYSTAL that were published in the April 2009 issue of the New England Journal of Medicine.
› Verified 2 days ago
Premier Healthcare Stl Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 703 Hesemann Ridge Ct, Ballwin, MO 63021 Phone: 636-751-0362 | |
Safe Transitions Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 452 Sovereign Ct Ste A, Ballwin, MO 63011 Phone: 914-376-6100 Fax: 914-470-5056 | |
Safe Transitions Md Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 452 Sovereign Ct Ste A, Ballwin, MO 63011 Phone: 636-222-8699 Fax: 636-238-5434 | |
Quality Chiropractic Healthcare Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 737 Whispering Forest Dr, Ballwin, MO 63021 Phone: 314-662-6678 | |
Culture Of Wellness, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 930 Kehrs Mill Rd Ste 325-3, Ballwin, MO 63011 Phone: 636-489-9259 | |
Our Urgent Care Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1742 Carman Ridge Ct, Ballwin, MO 63021 Phone: 314-610-6354 | |
Ballwin Eye Associates Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 118 Ramsey Ln, Ballwin, MO 63021 Phone: 636-227-5524 Fax: 636-227-9134 |